BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 28567557)

  • 1. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.
    Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV
    Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosus.
    Kim HA; Chun HY; Kim SH; Park HS; Suh CH
    J Rheumatol; 2009 Oct; 36(10):2238-43. PubMed ID: 19755616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
    Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
    Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population.
    Atisha-Fregoso Y; Lima G; Carrillo-Maravilla E; Posadas-Sánchez R; Pérez-Hernández N; Baños-Peláez M; Iturralde-Chávez A; Hernández-Díaz N; Jakez-Ocampo J; Rodríguez-Pérez JM; Vargas-Alarcón G; Llorente L; Romero-Díaz J
    Clin Rheumatol; 2018 Jul; 37(7):1817-1824. PubMed ID: 29556849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.
    Baltus TH; Kallaur AP; Lozovoy MA; Morimoto HK; Delongui F; Alfieri DF; Iriyoda TM; Dichi I; Simão AN; Reiche EM
    Rheumatol Int; 2016 Jan; 36(1):7-15. PubMed ID: 26071874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of - 717 A > G (rs2794521) CRP polymorphism with high cardiovascular risk by C-reactive protein in systemic lupus erythematosus patients.
    Pesqueda-Cendejas K; Parra-Rojas I; Meza-Meza MR; Mora-García PE; Campos-López B; Ruiz-Ballesteros AI; Montoya-Buelna M; Rivera-Escoto M; Moreno-Ortiz JM; Bautista-Herrera LA; Cerpa-Cruz S; De la Cruz-Mosso U
    Clin Rheumatol; 2023 Mar; 42(3):761-772. PubMed ID: 36355253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
    Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
    Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
    Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
    Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study.
    Panda AK; Tripathy R; Das BK
    Lupus; 2021 Feb; 30(2):219-227. PubMed ID: 33176568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
    Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
    Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.
    Mousa TG; Omar HH; Emad R; Salama MI; Omar W; Fawzy M; Hassoba HM
    Clin Rheumatol; 2019 Mar; 38(3):777-784. PubMed ID: 30374748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of rs531564 Polymorphism in the Primary MicroRNA-124 Gene in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Association with Disease Susceptibility and Clinical Characteristics.
    Hassani M; Dehani M; Zare Rafie M; Esmaeilzadeh E; Davar S; Pakzad B; Mosallaei M; Hoseini SM; Bayat H; Soosanabadi M
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):303-313. PubMed ID: 34134452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE.
    Mohammadoo-Khorasani M; Salimi S; Tabatabai E; Sandoughi M; Zakeri Z; Farajian-Mashhadi F
    Indian J Med Res; 2016 May; 143(5):591-6. PubMed ID: 27488002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
    Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
    Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPN22 1858C > T polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis update.
    de Lima SC; Adelino JE; Crovella S; de Azevedo Silva J; Sandrin-Garcia P
    Autoimmunity; 2017 Nov; 50(7):428-434. PubMed ID: 28990435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.
    Wu CJ; Guo J; Luo HC; Wei CD; Wang CF; Lan Y; Wei YS
    Rheumatol Int; 2016 Jan; 36(1):45-52. PubMed ID: 26289938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -675 4G/5G
    Anaya-Macias BU; De la Cruz-Mosso U; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla G; González-López L; Gámez-Nava JI; Pérez-Guerrero EE; Barrientos-Avalos SL; Muñoz-Valle JF
    Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients.
    Shojaa M; Aghaie M; Amoli M; Javid N; Shakeri F; Khashayar P; Tabarraei A; Keshtkar AA; Joshaghani HR; Kouroshnia A; Qorbani M; Mahmoudi F; Mohebbi R; Ranjbarpour N
    Int J Rheum Dis; 2017 Dec; 20(12):2040-2044. PubMed ID: 24400885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
    Lee YH; Song GG
    Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.